Advertisement
    In the last 2 hours
    Earlier today
    The thinness trap The Telegraph, Calcutta03:40
    Yesterday
    Semaglutide, Tirzepatide Cut Dementia, Stroke Risk in Type 2 Diabetes American Journal of Managed Care20:30 18-Jul-25
    New obesity drug could slow down breast cancer growth Knowridge Science Report11:30 18-Jul-25
    In the last 7 days
    Rollout of Weight Loss Injections Knowsley News16:31 17-Jul-25
    5 things doctors want you to know before taking Ozempic Australian Financial Review23:57 15-Jul-25
    Colorectal Cancer Shared Care Model Gains Support From Clinicians American Journal of Managed Care18:20 14-Jul-25
    Peptide Purgatory: Abandon All Protocol, Ye Who Enter Here The Nittany Turkey (Weblog)17:54 14-Jul-25
    Prenatal Air Pollution Exposure May Influence Childhood Obesity Risk American Journal of Managed Care13:56 14-Jul-25
    FDA Reviewing Sotatercept-csrk Label Expansion for PAH American Journal of Managed Care13:25 14-Jul-25
    In the last month
    Gaps in Molecular Testing Rates, Targeted Treatment Persist in MDS, AML American Journal of Managed Care12:22 11-Jul-25
    Prenatal and Early-Life Contributors to Childhood and Adolescent Obesity American Journal of Managed Care15:01 10-Jul-25
    Diabetes deprescribing . . . and other research British Medical Journal13:22 10-Jul-25
    Itepekimab Shows Mixed Results in Phase 3 COPD Trials American Journal of Managed Care19:52 9-Jul-25
    Cachexia Worsens Prognosis in Older Patients With Advanced SCLC American Journal of Managed Care14:17 9-Jul-25
    Genetic link between obesity drugs, pancreas damage probed The Columbian, Washington14:09 8-Jul-25
    Weight loss drugs may reduce effectiveness of the pill Anglia Ruskin University17:23 7-Jul-25
    Carrot Unveils New Program to Redefine Metabolic-Fertility Care PR Newswire (Press Release)14:02 7-Jul-25
    view more headlines
    19 Jul 20:31

    About our Tirzepatide news

    Latest news on Tirzepatide, a drug that is being developed as a potential treatment for obesity and type 2 diabetes. It is a synthetic hormone that is designed to mimic the effects of natural hormones called incretins, which help to lower blood sugar and reduce appetite. Tirzepatide has shown promise in clinical trials, producing significant weight loss in people with obesity or type 2 diabetes. It is administered as a once-weekly injection, and it is believed to work by increasing the production of a hormone called GLP-1, which helps to regulate appetite and insulin production. Tirzepatide is currently in late-stage clinical trials, and it is expected to be considered for regulatory approval in the coming years.


    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.